Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

J&J Revamps, Cuts Jobs

by Ann M. Thayer
November 9, 2009 | A version of this story appeared in Volume 87, Issue 45

Johnson & Johnson is restructuring to improve its operating efficiency through more simplified processes and fewer layers of management. J&J says this latest move will cut 6–7% of its workforce, or between 7,000 and 8,000 jobs, and generate up to $1.7 billion in annual savings when fully implemented by 2011. The goal is to position J&J for growth by freeing up resources to invest in new opportunities and support product launches, said CEO William C. Weldon in a conference call with analysts. The company will not change its decentralized style of running multiple, diversified subsidiaries, he emphasized. As a result, cutbacks will be made broadly across all three business areas—pharmaceuticals, consumer products, and medical devices and diagnostics—at the operating company level. Weldon also pointed out that the driver was the challenging external business environment and not internal issues, as had been the case for a restructuring in 2007. Nor is the realignment intended to address proposed, and still uncertain, changes in U.S. health care policy. In fact, he added, many of the cutbacks are likely to be outside the U.S.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.